Cardiovascular Systems Inc 4
4 · Cardiovascular Systems Inc · Filed Sep 23, 2013
Insider Transaction Report
Form 4
Flaherty James E
Chief Administrative Officer
Transactions
- Sale
Common Stock
2013-09-19$20.32/sh−1,882$38,242→ 140,920 total - Sale
Common Stock
2013-09-20$19.82/sh−184$3,647→ 140,736 total
Holdings
- 19,388
Stock Option (right to buy)
Exercise: $7.90Exp: 2017-08-06→ Common Stock (19,388 underlying) - 24,120
Stock Option (right to buy)
Exercise: $12.15Exp: 2017-12-11→ Common Stock (24,120 underlying) - 10,999
Stock Option (right to buy)
Exercise: $8.75Exp: 2019-03-02→ Common Stock (10,999 underlying) - 8,624
Stock Option (right to buy)
Exercise: $8.83Exp: 2017-04-17→ Common Stock (8,624 underlying)
Footnotes (4)
- [F1]In connection with the vesting and delivery of restricted stock and pursuant to a Rule 10b5-1 trading plan, on the date the shares were sold the net proceeds were used to pay required withholding taxes.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.10 to $20.79 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.80 to $20.02 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Fully exercisable.